Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.1 USD | -0.77% | +1.04% | +31.61% |
05-13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
05-08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.61% | 2.29B | |
-5.27% | 12.32B | |
-3.86% | 8.07B | |
+31.06% | 5.52B | |
-7.35% | 4.21B | |
-54.90% | 2.99B | |
+13.62% | 2.73B | |
-3.39% | 2.43B | |
-4.31% | 1.89B | |
+3.89% | 1.6B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Transcript : Myriad Genetics, Inc., Q1 2024 Earnings Call, May 07, 2024